MX2018000963A - Composicion farmaceutica sinergica del enantiomero activo s-ketorolaco trometamina y clorhidrato de tramadol. - Google Patents
Composicion farmaceutica sinergica del enantiomero activo s-ketorolaco trometamina y clorhidrato de tramadol.Info
- Publication number
- MX2018000963A MX2018000963A MX2018000963A MX2018000963A MX2018000963A MX 2018000963 A MX2018000963 A MX 2018000963A MX 2018000963 A MX2018000963 A MX 2018000963A MX 2018000963 A MX2018000963 A MX 2018000963A MX 2018000963 A MX2018000963 A MX 2018000963A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical composition
- tramadol hydrochloride
- ketorolac tromethamine
- active enantiomer
- synergistic pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a una composición farmacéutica que comprende la combinación sinérgica de un AINE, como lo es el principio activo: S-Ketorolaco de trometamina y un agente opioide, como lo es el principio activo: Clorhidrato de tramadol, los cuales se encuentran formulados con excipientes farmacéuticamente aceptables, misma que está indicada para el control y tratamiento del dolor leve y/o moderado y/o severo.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2018000963A MX2018000963A (es) | 2018-01-22 | 2018-01-22 | Composicion farmaceutica sinergica del enantiomero activo s-ketorolaco trometamina y clorhidrato de tramadol. |
PCT/MX2019/000003 WO2019143234A1 (es) | 2018-01-22 | 2019-01-22 | Combinación farmacéutica sinérgica del enantiómero activo s-ketorolaco trometamina y clorhidrato de tramadol |
CA3073186A CA3073186C (en) | 2018-01-22 | 2019-01-22 | Synergistic pharmaceutical combination of the active enantiomer s-ketorolac tromethamine and tramadol chlorhydrate |
EP19741419.6A EP3741369A4 (en) | 2018-01-22 | 2019-01-22 | SYNERGIC PHARMACEUTICAL COMBINATION OF THE ACTIVE ENANTIOMER S-KETOROLAC TROMETHAMINE AND TRAMADOL HYDROCHLORIDE |
US16/963,672 US20210069151A1 (en) | 2018-01-22 | 2019-01-22 | Synergistic pharmaceutical combination of the active enantiomer s-ketorolac tromethamine and tramadol chlorhydrate |
CONC2020/0001881A CO2020001881A2 (es) | 2018-01-22 | 2020-02-20 | Combinación farmacéutica sinérgica del enantiómero activo s-ketorolaco trometamina y clorhidrato de tramadol |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2018000963A MX2018000963A (es) | 2018-01-22 | 2018-01-22 | Composicion farmaceutica sinergica del enantiomero activo s-ketorolaco trometamina y clorhidrato de tramadol. |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018000963A true MX2018000963A (es) | 2018-12-13 |
Family
ID=65359454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018000963A MX2018000963A (es) | 2018-01-22 | 2018-01-22 | Composicion farmaceutica sinergica del enantiomero activo s-ketorolaco trometamina y clorhidrato de tramadol. |
Country Status (6)
Country | Link |
---|---|
US (1) | US20210069151A1 (es) |
EP (1) | EP3741369A4 (es) |
CA (1) | CA3073186C (es) |
CO (1) | CO2020001881A2 (es) |
MX (1) | MX2018000963A (es) |
WO (1) | WO2019143234A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113679676A (zh) * | 2020-05-19 | 2021-11-23 | 南京海融医药科技股份有限公司 | 一种左酮咯酸的药物组合物及其制备方法 |
US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3652589A (en) | 1967-07-27 | 1972-03-28 | Gruenenthal Chemie | 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols |
US4089969A (en) | 1976-07-14 | 1978-05-16 | Syntex (U.S.A.) Inc. | 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof |
US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
WO2002010828A2 (en) | 2000-07-27 | 2002-02-07 | Zetetic Institute | Control of position and orientation of sub-wavelength aperture array in near-field microscopy |
EP1420820A4 (en) | 2001-07-31 | 2005-04-06 | Univ Texas | ANTIGENS AND ANTIBODIES FOR TRANSLOQUED MOLECULES OF MICROORGANISMS AND USES THEREOF |
MXPA02010828A (es) * | 2002-11-04 | 2004-07-16 | Leopoldo Espinosa Abdala | Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor. |
US9265732B2 (en) | 2006-03-06 | 2016-02-23 | Pozen Inc. | Dosage forms for administering combinations of drugs |
MX2007003948A (es) | 2007-04-02 | 2009-02-25 | World Trade Imp Export Wtie Ag | Composicion farmaceutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor. |
MX2010011193A (es) | 2010-10-12 | 2012-04-18 | World Trade Imp Exp Wtie Ag | Composicion farmaceutica liquida para el tratamiento y prevencion del dolor. |
WO2013163142A1 (en) * | 2012-04-25 | 2013-10-31 | Yung Shin Pharm. Ind. Co., Ltd. | Liquid pharmaceutical formulation containing ketorolac and tramadol |
MX366757B (es) * | 2013-05-14 | 2019-07-23 | Laboratorio Raam De Sahuayo S A De C V | Sales del enantiomero activo s-ketorolaco. |
MX2013011079A (es) * | 2013-09-26 | 2015-06-10 | Inst De Investigacion En Quimica Aplic S A De C V | Composiciones farmaceuticas para el tratamiento del dolor agudo y neuropatico con base en el enantiomero activo (+)- tramadol o sus sales. |
MX2014005153A (es) | 2014-04-29 | 2015-10-28 | Liomont S A De C V Lab | Proceso de obtencion y composicion farmaceutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor. |
MX2014005152A (es) | 2014-04-29 | 2015-10-28 | Liomont S A De C V Lab | Composicion farmaceutica para el tratamiento de alopatias relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol. |
-
2018
- 2018-01-22 MX MX2018000963A patent/MX2018000963A/es unknown
-
2019
- 2019-01-22 EP EP19741419.6A patent/EP3741369A4/en active Pending
- 2019-01-22 CA CA3073186A patent/CA3073186C/en active Active
- 2019-01-22 US US16/963,672 patent/US20210069151A1/en active Pending
- 2019-01-22 WO PCT/MX2019/000003 patent/WO2019143234A1/es unknown
-
2020
- 2020-02-20 CO CONC2020/0001881A patent/CO2020001881A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2019143234A1 (es) | 2019-07-25 |
US20210069151A1 (en) | 2021-03-11 |
CA3073186C (en) | 2020-11-17 |
CA3073186A1 (en) | 2019-07-25 |
EP3741369A1 (en) | 2020-11-25 |
EP3741369A4 (en) | 2021-05-19 |
CO2020001881A2 (es) | 2020-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022007915A (es) | Compuestos de benzopirazol y analogos de estos. | |
MX2021004110A (es) | Composiciones farmaceuticas que comprenden n-(3,5- dimetoxifenil)-n'-(1-metiletil)-n-[3-(1-metil-1h- pirazol-4-il)quinoxalin-6-il]etano-1,2-diamina. | |
MX2019012884A (es) | Terapia de combinacion. | |
EA201990424A1 (ru) | Спиролактамовые модуляторы nmda-рецептора и их применение | |
EA201990428A1 (ru) | Спиролактамовые модуляторы nmda-рецептора и их применение | |
MX2020009235A (es) | Formulacion oftalmica. | |
MX2022002196A (es) | Composición de liberación retardada de niclosamida y uso antiviral de la misma. | |
SA521422467B1 (ar) | مركبات هالو-آلِّيلامين واستخدامها | |
PH12020551772A1 (en) | Oxo-substituted compound | |
IL307992A (en) | Parasitic formulations containing isoxazoline and methods for treating blepharitis | |
PH12021550687A1 (en) | Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or its salt | |
PH12019500618A1 (en) | Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease | |
MX2018000963A (es) | Composicion farmaceutica sinergica del enantiomero activo s-ketorolaco trometamina y clorhidrato de tramadol. | |
PH12019502652A1 (en) | 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases | |
MX2022003830A (es) | Compuesto de n-(1h-imidazol-2-il)benzamida y composicion farmaceutica que comprende el mismo como ingrediente activo. | |
MX2023011203A (es) | Derivado de cumarina para terapia o profilaxis de un trastorno proliferativo celular. | |
JOP20190054B1 (ar) | مركبات إندازول للاستخدام في إصابات الأوتار و/ أو الرباط | |
MX2021010596A (es) | Composicion farmaceutica que contiene oseltamivir. | |
WO2015166418A3 (es) | Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol | |
WO2019035646A8 (ko) | 세포사멸 수용체 저해제를 유효성분으로 포함하는 cx3cl1 케모카인 과발현으로 인한 질환 예방 또는 치료용 조성물 | |
WO2020013776A3 (en) | Synergistic effect of naproxen and a gastro protective agent for the treatment of pain and inflammation | |
MX2021011795A (es) | Composición farmaceutica que comprende esomeprazol 0 sal farmaceuticamente aceptable del mismo y que tiene un perfil de liberación doble. | |
MX2021004586A (es) | Uso de dosis mas altas de formulaciones de huperzina de liberacion modificada. | |
MX2022000426A (es) | Telmisartan para el tratamiento de la hipertension en perros. | |
MX2022000373A (es) | Combinacion de ibuprofeno y tramadol para aliviar el dolor. |